Nolotil (Metamizole Magnesium)

Metamizole magnesium works by inhibiting cyclooxygenase enzymes, which lowers prostaglandin production, and by modulating central pain pathways in the spinal cord and brain. This combination reduces the perception of pain and helps lower elevated body temperature.

The dose of Nolotil is determined by the prescribing clinician based on the patient’s condition, age, weight, and clinical response. Healthcare professionals adjust the amount and frequency according to standard medical guidelines and individual patient needs.

Safety data for metamizole magnesium during pregnancy and lactation are limited. It should only be used when the potential benefit justifies any possible risk to the fetus or infant, and the decision must be made by a qualified healthcare provider.

To order Nolotil, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and import documentation.

Compared with traditional NSAIDs, Nolotil offers potent analgesic and antipyretic effects with less anti‑inflammatory activity. Unlike opioids, it does not act on opioid receptors, reducing the risk of dependence, but it carries a rare risk of agranulocytosis, which requires blood‑count monitoring.

Nolotil should be stored at ambient temperature, protected from light and moisture, and kept in its original packaging. Vials must not be frozen or shaken vigorously. Follow standard aseptic techniques when preparing for intramuscular or intravenous administration.

Nolotil is supplied as a sterile injectable solution and is administered by a qualified healthcare professional either intramuscularly or intravenously, depending on the clinical situation and physician’s judgment.

The most serious risks include agranulocytosis, a potentially life‑threatening drop in white blood cells, and severe allergic reactions such as anaphylaxis or Stevens‑Johnson syndrome. Prompt medical attention is required if signs of infection, rash, or breathing difficulty occur.

Nolotil should be avoided in patients with known hypersensitivity to metamizole or other pyrazolones, those with existing severe bone‑marrow suppression, and individuals with a history of agranulocytosis. Caution is also advised for patients with renal impairment or those receiving other myelotoxic drugs.